研究業績

HOME > 医療関係・研究者の方へ > 研究業績

2014年度研究業績

原著論文 | 著書・訳書 | 症例報告 | 報告書 | 総説 | その他
戻る

[原著論文]

Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T: High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia. Psychiatry Clin Neurosci 68(1): 78-82, 2014.

Egawa J, Watanabe Y, Endo T, Kitamura H, Someya T: Possible association between the oxytocin receptor gene and N-acetylaspartate of the right medial temporal lobe in autism spectrum disorders (letter). Psychiatry Clin Neurosci 68(1): 83, 2014.

Suzuki Y, Ono S, Tsuneyama N, Sawamura K, Sugai T, Fukui N, Watanabe J, Someya T: Effects of olanzapine on the PR and QT intervals in patients with schizophrenia. Schizophr Res 152(1): 313-314, 2014.

Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Suzuki Y, Someya T: Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia. PLoS One 9(1): e86826, 2014.

Shibuya M, Watanabe Y, Nunokawa A, Egawa J, Kaneko N, Igeta H, Someya T: Interleukin 1 beta gene and risk of schizophrenia: Detailed case-control and family-based studies and an updated meta-analysis. Hum Psychopharmacol Clin Exp 29(1): 31-37, 2014.

Watanabe Y, Shibuya M, Someya T: The cardiomyopathy-associated 5 (CMYA5) gene and risk of schizophrenia: Meta-analysis of rs3828611 and rs4704591 in East Asian populations (letter). Asian J Psychiatr 7(1): 95-96, 2014.

Nakamura K, Kitamura K, Someya T: Psychological recovery five years after the 2004 Niigata-Chuetsu earthquake in Yamakoshi, Japan. J Epidemiol 24(2): 125-131, 2014.

Watanabe Y, Hishimoto A, Shibuya M, Nunokawa A, Kaneko N, Igeta H, Egawa J, Mouri K, Sora I, Someya T: A rare MIR138-2 gene variation is associated with schizophrenia in a Japanese population (letter). Psychiatry Res 215(3): 801-802, 2014.

Okazaki S, Watanabe Y, Hishimoto A, Sasada T, Mouri K, Shiroiwa K, Eguchi N, Ratta-Apha W, Otsuka I, Nunokawa A, Kaneko N, Shibuya M, Someya T, Shirakawa O, Sora I: Association analysis of putative cis-acting polymorphisms of interleukin-19 gene with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 50: 151-156, 2014.

Igeta H, Suzuki Y, Tajiri M, Someya T: Cardiovascular pharmacodynamics of donepezil hydrochloride on the PR and QT intervals in patients with dementia. Hum Psychopharmacol Clin Exp 29(3): 292-294, 2014.

Suzuki Y, Sugai T, Ono S, Sawamura K, Fukui N, Watanabe J, Tsuneyama N, Saito M, Someya T: Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia. Psychiatry Clin Neurosci 68(5): 353-356, 2014.

Kunii Y, Miura I, Matsumoto J, Hino M, Wada A, Niwa S, Nawa H, Sakai M, Someya T, Takahashi H, Kakita A, Yabe H: Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 53: 123-128, 2014.

Fukui N, Suzuki Y, Sugai T, Watanabe J, Ono S, Tsuneyama N, Someya T: Promoter variation in the catechol-O-methyltransferase gene is associated with remission of symptoms during fluvoxamine treatment for major depression. Psychiatry Res 218(3): 353-355, 2014.

Tachibana A, Kitamura H, Shindo M, Honma H, Someya T: Psychological distress in an earthquake-devastated area with pre-existing high rate of suicide. Psychiatry Res 219(2): 336-340, 2014.

Suzuki Y, Tsuneyama N, Fukui N, Sugai T, Watanabe J, Ono S, Saito M, Inoue Y, Someya T: Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia. Pharmacogenomics J 14(5): 452-456, 2014.